What a CAC score of zero actually means for your cardiovascular risk

You got a coronary artery calcium scan — maybe because your LDL was borderline, or your cardiologist wanted to sharpen a statin decision. The result came back zero. That's good news. But "zero" gets misunderstood in both directions: some people treat it as permanent clearance, others dismiss it as meaningless. Here's what it actually means, how long it's valid, and what it changes.

What the scan is measuring

A coronary artery calcium (CAC) scan is a low-dose CT scan of the chest that detects and quantifies calcium deposits in the walls of the coronary arteries. Calcium accumulates in atherosclerotic plaque as part of the healing process — it's a marker of the presence of established plaque, even if the plaque itself isn't causing any symptoms or obstruction.

The score is reported as an Agatston score — a calculation that accounts for both the density and the area of calcified deposits. A score of zero means no calcified plaque was detected in any of the major coronary arteries.

What's important to understand: CAC specifically measures calcified plaque. Early atherosclerosis often involves soft (non-calcified) plaque — lipid-rich deposits that haven't yet undergone calcification. A score of zero doesn't confirm an absence of all plaque; it confirms an absence of calcified plaque, which is typically a later stage of disease. This distinction matters most in younger adults and is worth keeping in mind.

What the evidence shows about CAC zero and event risk

The prognostic data on CAC zero is robust and comes primarily from the MESA (Multi-Ethnic Study of Atherosclerosis) cohort — a landmark study that followed over 6,800 adults for up to 15 years and tracked cardiovascular events by baseline CAC score.

The key findings:

  • Adults with CAC = 0 had a 10-year cardiovascular event rate of approximately 0.8–1.5% in most intermediate-risk subgroups — substantially lower than the 7.5% threshold that typically triggers statin consideration in the pooled cohort equations
  • Even adults with multiple traditional risk factors (elevated LDL, hypertension, current smoking) but CAC = 0 had 10-year event rates below 3%
  • The "negative risk" of CAC zero — its ability to reclassify intermediate-risk adults to low-risk — was consistent across sex, age, and race/ethnicity groups

This is why the 2026 AHA dyslipidemia guideline specifically endorses using CAC to guide statin decisions in adults where the treatment choice is genuinely uncertain — the "statin benefit zone" is primarily adults with borderline to intermediate 10-year risk who have factors for and against treatment. In those adults, a CAC of zero is formal grounds for deferring medication and focusing on lifestyle.

How long CAC zero is valid

CAC zero is not a permanent finding. Plaque develops and calcifies over time, and the protective predictive value of a zero score diminishes as age and risk factor exposure accumulate.

The MESA data provides the best estimate: in intermediate-risk adults, CAC zero maintains its strong negative predictive value for approximately 5–7 years. After that window, meaningful calcification can develop as the result of ongoing LDL and Lp(a) exposure, especially in adults who didn't address underlying risk factors during the low-risk period.

Practically, this means:

  • If you're 48 with borderline LDL and your CAC comes back zero, deferring a statin for 5 years is clinically reasonable — with active lifestyle management in the interim
  • If you're 58 with a CAC zero from 6 years ago, that data is increasingly stale; a rescan or reconsidering treatment based on current risk factor trajectory is appropriate
  • If you're 38 with elevated LDL and a CAC zero, you have more runway — but the soft-plaque caveat becomes more relevant the younger you are, since calcification lags years behind lipid-driven plaque formation

What CAC zero doesn't change

This is the part that most people miss. A CAC score of zero is grounds for deferring medication in borderline-risk adults — it is not grounds for ignoring the underlying numbers that generated concern in the first place.

Elevated LDL still needs addressing. An LDL of 145 with a CAC of zero doesn't mean LDL 145 is suddenly fine. It means you haven't yet accumulated enough plaque to show calcification — and the clock on that gap is running. Lifestyle measures to lower LDL are still indicated. If ApoB is elevated, that still matters. The LDL risk-tier framework still applies to your target.

Elevated Lp(a) still needs tracking. Lp(a) is an independent cardiovascular risk factor that contributes to plaque formation independently of calcification status. The AHA's position is that Lp(a) above 125 nmol/L is a risk-enhancer that should lower the threshold for treatment regardless of CAC score. See the complete Lp(a) guide for why this matters specifically alongside a CAC zero result.

Blood pressure, glucose, and smoking remain independent risk factors that CAC zero doesn't neutralize. The scan informs one dimension of the risk picture — current calcified plaque burden. The other dimensions continue to accumulate risk regardless of scan results.

When CAC zero does and doesn't change the treatment decision

The 2026 AHA guideline is specific about when CAC is useful as a decision tool. It's most valuable for adults in the borderline or intermediate-risk band — those with a 10-year ASCVD risk of 5–19.9% — where the statin decision is genuinely uncertain and could reasonably go either way based on risk factors alone.

CAC zero defers statin therapy when:

  • 10-year ASCVD risk is borderline (5–7.5%) or intermediate (7.5–20%) and the patient and clinician are uncertain about whether to start a statin
  • LDL is in the 100–159 mg/dL range without other compelling indications
  • There are no high-risk conditions (diabetes, CKD, established ASCVD, very high Lp(a), FH)

CAC zero does not typically override statin therapy when:

  • LDL is ≥190 mg/dL (familial hypercholesterolemia territory) — statin is indicated regardless
  • Type 2 diabetes with age ≥40 and other risk factors — guideline recommendation is statin therapy regardless of CAC
  • Lp(a) is very high (above 250 nmol/L) — the soft-plaque and thrombotic risk pathway is active even with CAC zero
  • Established cardiovascular disease — secondary prevention recommendations apply regardless

If you're uncertain whether your situation fits the "CAC changes the decision" criteria, the CAC scan decision tool walks through whether a scan would actually move the needle for your specific profile — or whether you're already clearly in the "treat" or "don't treat" category where CAC wouldn't add information.

The practical takeaway

A CAC score of zero is real, meaningful news. It significantly reduces your near-term cardiovascular event risk relative to the estimate from your risk factors alone, and in borderline or intermediate-risk adults it's a legitimate basis for deferring statin therapy for approximately 5 years.

What it is not: a clean bill of health, a reason to abandon lifestyle management, or a permanent result. The risk factors that led to the scan are still there, still accumulating exposure, and will eventually produce calcification if not managed. CAC zero buys time and changes the urgency — it doesn't remove the underlying question.

Use the time well: reduce LDL through lifestyle, address triglycerides if elevated, understand your Lp(a), and retest in 5–7 years or sooner if your risk profile changes. The lipid panel translator helps you track all these markers together.

Educational resource. Not medical advice. See our methodology and citations.